Loading market dashboard
Rallybio Corporation
RLYBHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Rallybio Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $89.00M | $89.00M - $89.00M | $17.80M | $3.92 | 1 |
| Dec 2028 | $87.50M | $87.50M - $87.50M | $17.50M | -$3.12 | 1 |
| Dec 2027 | $87.90M | $87.90M - $87.90M | $17.58M | -$11.52 | 1 |
| Dec 2026 | $80.0K | $80.0K - $80.0K | $16.0K | -$5.52 | 2 |
| Dec 2025 | $700.0K | $572.7K - $763.6K | $140.0K | -$1.80 | 3 |
| Dec 2024 | $673.8K | $673.8K - $673.8K | $134.7K | -$11.36 | 2 |